Table 1.
Site | Number | Stage I,II,III,IV | Ascites | Port-site Metastases Cases (No.of Sites) |
---|---|---|---|---|
Endometrium | 39 | 32,2,5,0 | 1 | 0 |
Primary | 37 | 31,2,4,0 | 1 | 0 |
Recurrent | 2 | 1,0,1,0 | 0 | 0 |
Ovarian Epithelium | 29 | 6,1,20,2 | 7 | 0 |
Primary | 10 | 5,1,2,2 | 4 | 0 |
Recurrent | 19 | 1,0,18,0 | 3 | 1(5) |
Cervix | 14 | 6,6,0,2 | 2 | 0 |
Primary | 12 | 6,4,0,2 | 2 | 0 |
Recurrent | 2 | 0,2,0,0 | 0 | 0 |
Sarcoma of Uterus or Ovary | 3 | – | 0 | 0 |
Primary | 1 | – | 0 | 0 |
Recurrent | 2 | – | 0 | 0 |
Metastatic Breast | 2 | 0,0,0,2 | 0 | 0 |
Fallopian Tube | 2 | 1,1,0,0 | 0 | 0 |
Primary Peritoneum Recurrent | 1 | 0,0,1,0 | 1 | 1(3) |
One patient had a synchronous ovarian and endometrial cancer, and two patients had a synchronous ovarian and cervical cancer.